Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update
出版年份 2015 全文链接
标题
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 22, Pages 6820-6834
出版商
Baishideng Publishing Group Inc.
发表日期
2017-09-18
DOI
10.3748/wjg.v21.i22.6820
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease
- (2015) Cemal F. Subasi et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
- (2015) Jun Luo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening
- (2015) Giovanni Musso et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease is associated with progression of arterial stiffness
- (2015) N. Li et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Mortality From Chronic Liver Diseases in Diabetes
- (2014) Giacomo Zoppini et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- CKD and Nonalcoholic Fatty Liver Disease
- (2014) Giovanni Targher et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
- (2014) Christopher D. Byrne et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness
- (2014) Murat Sunbul et al. ATHEROSCLEROSIS
- Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease
- (2014) Svanhildur Haflidadottir et al. BMC GASTROENTEROLOGY
- Halting Arterial Aging in Patients with Cardiovascular Disease: Hypolipidemic and Antihypertensive Therapy
- (2014) Vasilios Papademetriou et al. CURRENT PHARMACEUTICAL DESIGN
- The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
- (2014) Niki Katsiki et al. CURRENT PHARMACEUTICAL DESIGN
- Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies
- (2014) Niki Katsiki et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of Rosuvastatin on Non-alcoholic Steatohepatitis in Patients with Metabolic Syndrome and Hypercholesterolaemia: A Preliminary Report
- (2014) Konstantinos Kargiotis et al. Current Vascular Pharmacology
- The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
- (2014) Yumie Takeshita et al. DIABETOLOGIA
- Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications
- (2014) Yuka Takahashi et al. HEPATOLOGY RESEARCH
- Chronic kidney disease and associated mortality after liver transplantation – A time-dependent analysis using measured glomerular filtration rate
- (2014) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population
- (2014) Xin-yan Yu et al. Journal of Zhejiang University-SCIENCE B
- Association of Fatty Liver Disease with Nonfatal Cardiovascular Events in Patients Undergoing Maintenance Hemodialysis
- (2014) Yu-Cheng Lai et al. NEPHRON CLINICAL PRACTICE
- Inhibition of Inducible Nitric Oxide Synthesis Ameliorates Liver Ischemia and Reperfusion Injury Induced Transient Increase in Arterial Stiffness
- (2014) T.-H. Chen et al. TRANSPLANTATION PROCEEDINGS
- Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
- (2014) Bülent Baran WORLD JOURNAL OF GASTROENTEROLOGY
- Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
- (2014) Chun-Meng Jiang WORLD JOURNAL OF GASTROENTEROLOGY
- Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
- (2014) Stefano Ballestri WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic fatty liver disease and cardiovascular disease
- (2014) Hong Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic fatty liver disease and vascular disease: State-of-the-art
- (2014) Silvia Fargion WORLD JOURNAL OF GASTROENTEROLOGY
- Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease—Is There a Link?
- (2014) L. Orlić et al. Gastroenterology Research and Practice
- Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
- (2014) Amedeo Lonardo et al. Expert Review of Gastroenterology & Hepatology
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Effects of Low-Dose Atorvastatin on Arterial Stiffness and Central Aortic Pressure Augmentation in Patients With Hypertension and Hypercholesterolemia
- (2013) A. I. Kanaki et al. AMERICAN JOURNAL OF HYPERTENSION
- Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure
- (2013) Dimitris Tousoulis et al. ATHEROSCLEROSIS
- Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes - a prospective observational cohort study
- (2013) Elsa M Dahlén et al. Cardiovascular Diabetology
- Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?
- (2013) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Statins and nonalcoholic fatty liver disease: a bright future?
- (2013) Vasilios G Athyros et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease
- (2013) Vasilios G Athyros et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Novel therapeutic targets for nonalcoholic fatty liver disease
- (2013) Akiko Eguchi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2013) Paul Angulo et al. GASTROENTEROLOGY
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Effects of Rosuvastatin vs. Simvastatin/ezetimibe on Arterial Wall Stiffness in Patients with Coronary Artery Disease
- (2013) Ban Liu et al. INTERNAL MEDICINE
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
- (2013) Akinobu Takaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents
- (2013) Anajás S. Cardoso et al. Jornal de Pediatria
- Metabolic syndrome and arterial stiffness
- (2013) Charalambos Koumaras et al. Journal of Cardiovascular Medicine
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
- (2013) Iliana Doycheva et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Uric acid, chronic kidney disease and type 2 diabetes: A cluster of vascular risk factors
- (2013) Vasilios G. Athyros et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease
- (2013) Kai-jiang Yu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness
- (2013) Charalambos Koumaras et al. Journal of the American Society of Hypertension
- Mechanisms of arterial calcifications and consequences for cardiovascular function
- (2013) Gérard M. London Kidney International Supplements
- Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
- (2012) Vassilios G. Athyros et al. Archives of Medical Science
- Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease
- (2012) Teoman Dogru et al. CLINICAL ENDOCRINOLOGY
- Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
- (2012) Konstantinos Tziomalos et al. Current Vascular Pharmacology
- Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
- (2012) Hideyuki Hyogo et al. DIGESTIVE AND LIVER DISEASE
- Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
- (2012) Michael S. Kostapanos et al. DIGESTIVE DISEASES AND SCIENCES
- NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
- (2012) Geoffrey C. Farrell et al. Gut and Liver
- Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
- (2012) Donghee Kim et al. HEPATOLOGY
- Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2012) Takashi Nakahara et al. HEPATOLOGY RESEARCH
- Hyperuricaemia
- (2012) Niki Katsiki et al. Journal of Cardiovascular Medicine
- Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease
- (2012) Ju-Yi Chen et al. Journal of the American Society of Hypertension
- Dysregulation of hepatic fatty acid metabolism in chronic kidney disease
- (2012) Kyubok Jin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Thinking Beyond Traditional Cardiovascular Risk Factors
- (2011) Niki Katsiki et al. ANGIOLOGY
- Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome
- (2011) Vassilios G. Athyros et al. ANGIOLOGY
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study
- (2011) Vassilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Relationship Between Arterial Stiffness and Nonalcoholic Fatty Liver Disease
- (2011) Yong-Jae Lee et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2011) Hideyuki Hyogo et al. HEPATOLOGY RESEARCH
- Effects of Atorvastatin on Arterial Stiffness in Chronic Kidney Disease: a Randomised Controlled Trial
- (2011) Robert G Fassett et al. Journal of Atherosclerosis and Thrombosis
- Yes! Statins can be given to liver patients
- (2011) Ted Bader JOURNAL OF HEPATOLOGY
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- (2010) J. K. Dowman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
- (2010) Masato Yoneda et al. HEPATOLOGY RESEARCH
- Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
- (2010) Hyohun Park et al. JOURNAL OF GASTROENTEROLOGY
- Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
- (2010) Yuki Kimura et al. JOURNAL OF GASTROENTEROLOGY
- Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
- (2010) Charalambos Vlachopoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
- (2010) Munechika Enjoji et al. Lipids in Health and Disease
- Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
- (2009) Tatjana Stojakovic et al. ATHEROSCLEROSIS
- Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
- (2009) Giovanni Targher et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study
- (2009) V. G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
- (2009) Kaisa Maki-Petaja et al. CURRENT PHARMACEUTICAL DESIGN
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes
- (2009) S. T. Hwang et al. INTERNAL MEDICINE JOURNAL
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
- (2009) G. Targher et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Chronic Kidney Disease in Japan
- (2008) Kunitoshi Iseki INTERNAL MEDICINE
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
- (2008) Hideyuki Hyogo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started